SIX · SREN.SW
Swiss Re AG
CHF 150.85+CHF 0.75 (+0.5%)
Swiss Re AG’s quoted price sits in the upper half of its reported 52-week range, 2.52% below the high.
Loading market information…
XETRA · MUV2.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München’s quoted price sits in the upper half of its reported 52-week range, 2.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München’s forward annual dividend is €24.00 per share, paid annual. The forward yield is 4.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of €11.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specialty Insurance, ERGO Life and Health Germany, ERGO Property-Casualty Germany, and ERGO International. The company offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, data analytics, underwriting and claims, medical research, capital management, and health market, as well as MIRA digital suite that includes MIRA PoS, MIRApply insured and physician, claims risk assessment, and CLARA plus. It also provides property and casualty reinsurance solutions, including agricultural reinsurance; business advisory, personal lines, portfolio management, insurance consulting, commercial motor consulting; infrastructure risk; property insurance, location risk, insurance linked securities, and NatCatSERVICE for natural catastrophe loss database; prospective structured and retroactive reinsurance; risk transfer; cyber; and data analytics, REALYTIX ZERO, and cert2go. In addition, the company offers solutions for industry clients, such as corporate risk, new tech, green tech, parametric, and aviation and space solutions, as well as risk services. Further, it provides specialty property casualty insurance, such as professional liability, marine, cyber, aviation, and space for commercial and private customers. Additionally, the company offers life, property-casualty, health, legal protection, and travel insurance products under the ERGO brand; and insurance solutions for agriculture, captive, epidemic, cyber, and renewable energy sectors. The company was founded in 1880 and is based in Munich, Germany.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Aug 8, 2025 |
| €16.09+19.99% vs estimate |
| €16.00B-3.54% vs estimate |
| Q1 2025 | May 13, 2025 | €8.34-27.54% vs estimate | €16.40B-11.57% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | €7.54+29.11% vs estimate | €15.05B-18.67% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | €7.02-29.59% vs estimate | €16.74B-5.43% vs estimate |
|---|
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 150.85+CHF 0.75 (+0.5%)
Swiss Re AG’s quoted price sits in the upper half of its reported 52-week range, 2.52% below the high.
€284.20+€2.60 (+0.92%)
Hannover Rück SE’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
$263.45+$2.47 (+0.95%)
Reinsurance Group of America, Incorporated’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
$400.59+$13.71 (+3.54%)
Everest Group, Ltd.’s quoted price sits in the upper half of its reported 52-week range, 2.58% below the high.
$338.66+$6.47 (+1.95%)
RenaissanceRe Holdings Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.92% below the high.
€33.02+€0.26 (+0.79%)
SCOR Se’s quoted price sits in the upper half of its reported 52-week range, 6.46% below the high.
HK$1.17+HK$0.01 (+0.43%)
China Reinsurance (Group) Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.68% below the high.
₹322.30-₹2.80 (-0.86%)
General Insurance Corporation of India’s quoted price sits in the lower half of its reported 52-week range, 22.89% below the high.
